Isabelle Martins Selected Research

Diazepam Binding Inhibitor

1/2021	Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index.
12/2020	Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects.
12/2019	Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.
11/2019	Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor.
10/2019	Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Martins Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 08/2009
9	Obesity 07/2021 - 10/2019
5	Necrosis 01/2017 - 11/2009
4	Starvation 01/2021 - 10/2019
3	Weight Gain 04/2022 - 10/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2012
3	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2012
3	Tetraploidy 11/2021 - 01/2013
3	Melanoma (Melanoma, Malignant) 06/2012 - 03/2007
2	Hypoxia (Hypoxemia) 01/2021 - 08/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2013
2	Carcinoma (Carcinomatosis) 08/2013 - 12/2012
1	Body Weight (Weight, Body) 04/2022
1	Amyloidosis 03/2022
1	Genetic Translocation (Chromosomal Translocation) 01/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Overnutrition 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2020
1	Anorexia Nervosa 01/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 11/2019
1	Weight Loss (Weight Reduction) 10/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Ascites 08/2013

Drug/Important Bio-Agent (IBA)

10	Adenosine Triphosphate (ATP)IBA 08/2013 - 11/2009
9	Proteins (Proteins, Gene)FDA Link 03/2022 - 10/2010
8	5-methoxy-methylindoleacetic acid (DBI)IBA 04/2022 - 10/2019
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2012
6	AnthracyclinesIBA 01/2021 - 02/2010
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 02/2010
5	Diazepam Binding InhibitorIBA 01/2021 - 10/2019
5	CalreticulinIBA 01/2020 - 12/2009
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 06/2012
5	AntigensIBA 01/2020 - 10/2010
4	LigandsIBA 01/2021 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2012
4	VaccinesIBA 10/2014 - 03/2012
3	Phosphotransferases (Kinase)IBA 01/2021 - 08/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 08/2017 - 03/2011
3	HMGB1 Protein (HMG1)IBA 08/2013 - 03/2012
3	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 08/2011
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2021
2	Acyl Coenzyme A (Acyl CoA)IBA 01/2021 - 12/2020
2	Pattern Recognition ReceptorsIBA 01/2021 - 05/2012
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 12/2020
2	CarcinogensIBA 01/2021 - 09/2012
2	HLA-DR Antigens (HLA-DR)IBA 08/2013 - 08/2009
2	Digoxin (Digitek)FDA LinkGeneric 12/2012 - 07/2012
2	Cytotoxins (Cytolysins)IBA 08/2012 - 10/2010
2	EnzymesIBA 05/2012 - 12/2011
2	Mitogen-Activated Protein KinasesIBA 08/2009 - 03/2007
1	gamma-Aminobutyric Acid (GABA)IBA 04/2022
1	Rosiglitazone (Avandia)FDA Link 04/2022
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	Protein AggregatesIBA 03/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	niraparibIBA 01/2022
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2022
1	NocodazoleIBA 11/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2021
1	GalactosidasesIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Poly I-CIBA 01/2021
1	ceritinibIBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	Annexin A1IBA 01/2021
1	LipidsIBA 01/2021
1	Red Fluorescent ProteinIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	factor AIBA 12/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020
1	Chloroquine (Aralen)FDA LinkGeneric 06/2020
1	ChloridesIBA 11/2019
1	Chloride Channels (Chloride Channel)IBA 11/2019
1	squaramideIBA 11/2019
1	LeptinIBA 10/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2019
1	Histone Deacetylase InhibitorsIBA 08/2017
1	abexinostatIBA 08/2017
1	LipopolysaccharidesIBA 01/2017
1	Biological ProductsIBA 01/2017
1	InterferonsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	CD3 ComplexIBA 08/2013
1	catumaxomabIBA 08/2013
1	Epithelial Cell Adhesion MoleculeIBA 08/2013
1	CytokinesIBA 02/2013

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2021 - 11/2009
11	Therapeutics 06/2020 - 02/2010
5	Radiotherapy 01/2018 - 01/2017
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 01/2017
1	Subcutaneous Injections 02/2013